PFE : Analysis & Opinions

  • Showing 1-100 of 135 items
  • 1
  • 2
  • >>
  1. Pfizer Stock Rises Despite Price Target Cut (PFE)

    June 21, 2016
    Shares of Pfizer rose as much as 1.37% Monday, reaching a session high of $34.69 even though the drug giant saw its price ...
  2. Oracle Scores Another Cloud Services Win

    June 20, 2016
    By virtually every measure, the cloud market is poised to explode in the coming months and years. One of the fastest-growing ...
  3. 3 Mutual Funds Poised to Perform in the Future (VGENX, FSPHX)

    June 19, 2016
    Learn about sector weightings in growth mutual funds versus the benchmark and how three funds are positioned to profit from ...
  4. Avoid Betting on These Acquisition Target Stocks (PFE, AGN)

    June 16, 2016
    Many target stocks high on acquirers list are trading at deep discounts. Here’s why investors should avoid them.
  5. Is Investment Banking Peaking? (PFE, AGN)

    June 15, 2016
    Learn about the numerous challenges facing investment banking and explore whether the industry is peaking.
  6. How M&A Breakups Are Hurting Investment Banks' Profits (PFE, ...

    June 14, 2016
    Discover what happens when mergers and acquisitions fail. Learn about three major deals that have fallen through in 2016 ...
  7. The Share Buyback Report: Health Care Sector (PFE, JNJ)

    June 3, 2016
    Analyze health care sector share repurchase data to identify trends. Determine which factors influence volume and which companies ...
  8. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  9. 5 Companies With Huge Cash Flow (AAPL,VZ,MSFT,WMT)

    June 1, 2016
    These five companies have major cash flow which makes them good long-term bets.
  10. Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)

    June 1, 2016
    The Botox maker got a much-needed dose of confidence Tuesday when the market learned that activist investor Carl Icahn had ...
  11. 3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN)

    May 28, 2016
    Discover three ETFs that were affected by the failed Pfizer and Allergan acquisition, and learn about the performances and ...
  12. VHT: Vanguard Health Care ETF Performance Analysis

    May 26, 2016
    Discover how the Vanguard Health Care ETF performed through bear and bull markets, and learn which holding is trouncing the ...
  13. Biotech ETFs: Why Valeant May Cause Contagion Risk (VRX)

    May 26, 2016
    Learn about Valeant Pharmaceutical's scandal that caused its stock to plunge over 90%, and why biotech ETF investors should ...
  14. CF Industries Drops Planned Purchase of OCI

    May 24, 2016
    A federal crackdown on tax inversion mergers has effectively killed a planned acquisition by fertilizer maker CF Industries' ...
  15. Pfizer Bets Big on Eczema With Anacor Acquisition

    May 23, 2016
    Pfizer seems to have made the right bet on Anacor to capture the present day $4 billion eczema medicine market.
  16. XenoPort Stock Rises Nearly 60% on Takeover News

    May 23, 2016
    It's a fine time to be a shareholder in biotech company XenoPort (NASDAQ: XNPT). The company revealed Monday that it has ...
  17. Pfizer Buys Anacor Pharmaceuticals For $5.2B (PFE, ANAC)

    May 17, 2016
    Pfizer, which last month ended its bid for Allergan, is looking to capitalize on Anacor's experimental gel used to treat ...
  18. Pfizer to Pay 55% Premium to Acquire Anacor

    May 16, 2016
    The share price of biotech company Anacor Pharmaceuticals (NASDAQ: ANAC) rose by nearly 60% Monday following news that it ...
  19. Allergan Stock Falls to New Low Ahead of Earnings (AGN, PFE)

    May 9, 2016
    Wall Street expects the maker of cosmetic injection Botox to deliver year-over-year declines in both revenue and profits.
  20. FKINX: Franklin Income Performance Case Study

    May 3, 2016
    Learn about the Franklin Income Fund's history, trends and performance for each quarter over the past decade.
  21. Pfizer Stock Rises Ahead of Earnings (PFE, AGN)

    May 2, 2016
    It turns out Pfizer might not have needed Allergan after all, given that PFE shares have surged 9% and 7.3% in the respective ...
  22. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  23. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  24. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  25. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  26. FKINX: Top 5 Holdings Analysis (FKINX, RDS-A)

    April 14, 2016
    Learn about the Franklin Income Fund Class A mutual fund and its legacy since inception in 1948, and review the income fund's ...
  27. Singer Gets Better End of AGN-PFE Deal Implosion

    April 12, 2016
    Paul Singer increased his stake in Allergen by 204.75% in the fourth quarter. How will this impact his portfolio since the ...
  28. Pfizer CEO: Let Us Invest in the U.S. (AGN, PFE)

    April 7, 2016
    Ian Read, Chairman and CEO of Pfizer, published an op-ed in the Wall Street Journal Wednesday, in which he defended the logical ...
  29. Allergan's Fall Hits Hedge Funds Hard (AGN, PFE)

    April 6, 2016
    When shares in Allergan dropped 14.8% to $236.55 on Tuesday, not everyone realized how much – and how many – hedge funds ...
  30. FAGIX: Fidelity Capital & Income Fund's Top 5 Holdings Analysis

    April 6, 2016
    Evaluate the top five holdings of the Fidelity Capital & Income Fund, and study the basics and recent performance of the ...
  31. Pfizer Withdraws Merger Bid With Allergan (AGN, PFE)

    April 6, 2016
    Pfizer has come to realize the U.S. Treasury Department's new stance with inversions: "Over my dead body."
  32. FPHAX: Fidelity Select Pharma Fund Portfolio Trends in 2016

    April 5, 2016
    Evaluate the composition of the Fidelity Select Pharmaceuticals Portfolio, and learn how the fund's makeup has evolved between ...
  33. Allergan Now Trades Cheaper Than Its Standalone Value

    April 5, 2016
    Shibani Malhotra of Nomura thinks Allergan plc Ordinary Shares (NYSE: AGN) is compelling, despite treasury notice that threatens ...
  34. The Market In 5 Minutes: Tuesday, April 5, 2016

    April 5, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  35. Allergan Crushed as Tax Inversion Rules Threaten PFE Deal (AGN, ...

    April 5, 2016
    Given the army of lawyers, not to mention lobbyists, on their respective payrolls, Allergen and Pfizer are not likely to ...
  36. VGHCX: Vanguard Healthcare Fund Top 5 Holdings Analysis

    April 2, 2016
    Find out which of the five largest health care companies hold the top five positions in the $46 billion Vanguard Health Care ...
  37. The Most Shorted Stocks and ETF (PFE,SPY,CHK,S)

    March 29, 2016
    These stocks and ETF are heavily shorted and have been rallying at breakneck speed. Will it continue?
  38. Pfizer Short Interest Continues to Rise (PFE)

    March 29, 2016
    Dating back to March 2015 the only ones to have made money on PFE stock have been the short sellers. Do they know something ...
  39. VGHCX: Portfolio Trends in 2016

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  40. 3 S&P 500 Stocks to Sell Short at the 50-Day EMA

    March 21, 2016
    The 50-day EMA works well with other indicators to identify short sale opportunities with market laggards.
  41. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  42. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  43. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  44. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  45. The 3 Biggest Healthcare Stocks in the S&P 500 ETF (SPY, JNJ)

    March 17, 2016
    Discover the three biggest health care companies in the SPY ETF, and learn how they could power your portfolio performance ...
  46. 5 Mutual Funds for Dividend Investors from Morningstar (VDIGX, ...

    March 16, 2016
    Find out which five highly rated dividend funds are Morningstar favorites for their strong yields and overall performance ...
  47. Healthcare Sector: Industries Snapshot (XLV, JNJ)

    March 15, 2016
    Discover the six industries that make up the health care sector in the Standard and Poor's 500, and learn which companies ...
  48. FKINX: Overview of Franklin Income Fund

    March 15, 2016
    Learn about the venerable Franklin Templeton Income Fund in this fund overview, including information about its investment ...
  49. 4 Reasons Behind Bill Ackman's Purchase of Zoetis Stock (ZTS, ...

    March 15, 2016
    Find out the reasons behind activist hedge fund manager Bill Ackman's 10% stake in Zoetis, Inc., and learn his plans for ...
  50. J&J's Partnership with IBM Could Turn Profitable (JNJ, IBM)

    March 12, 2016
    Learn why Johnson & Johnson teamed up with IBM, and which patient mobile apps will be part of their medical data analysis ...
  51. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  52. Analyzing Johnson & Johnson's Return on Equity (JNJ, PFE)

    March 6, 2016
    Learn about Johnson & Johnson's recent return on equity, what has driven the recent trends, and how it compares to competitors ...
  53. Analyzing Pfizer's Return on Equity (ROE) (PFE)

    March 5, 2016
    Analyze the return on equity (ROE) of Pfizer and understand how changes in the company's net margin have driven its ROE up ...
  54. Pfizer's 3 Key Financial Ratios (PFE)

    February 29, 2016
    Learn about three important financial ratios that help understand Pfizer, Inc. business and analyze the company's financial ...
  55. Is Pfizer Stock Suitable for Your IRA or Roth IRA? (PFE)

    February 28, 2016
    Discover why Pfizer's suitability in a Traditional IRA or Roth IRA depends on your interpretation of the company's current ...
  56. Don't Freak Out Over Black Swans; Be Prepared

    February 11, 2016
    Could 2016 be a big year for black swans? Who knows? Here's what black swans are, how they can devastate the unprepared, ...
  57. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  58. How the New Allergan Plc Will Make Money

    January 14, 2016
    Allergan plc is not only enormous, it's about to more than double in size. Here's why and how.
  59. Healthcare Stocks: Are These 2016's Best?

    January 13, 2016
    Healthcare stocks aren't likely to hold up as well as you think, but these three stocks could offer resiliency.
  60. The Biggest M&A Deals of 2015

    January 5, 2016
    Here is a summary of 2015 M&A activity and a look ahead at 2016.
  61. 5 Big M&A deals in 2015 (PFE, AGN)

    December 23, 2015
    Learn how these mergers and acquisitions helped make 2015 a boom year for M&A deals, with the total value of the companies ...
  62. Top 3 NYSE Listed Stocks for 2016 (BABA, PFE)

    December 23, 2015
    Learn about some of the stocks listed on the NYSE that may setting up for a big year in 2016. See how Alibaba has underperformed ...
  63. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  64. AstraZeneca Makes a $575 Million Acquisition (AZN, PFE)

    December 16, 2015
    Pharmaceutical giant AstraZeneca (NYSE: AZN) is shoring up its presence in a key segment. On Wednesday, the company announced ...
  65. The Top 5 Dividend Paying Healthcare Stocks for 2016 (JNJ, PFE)

    December 8, 2015
    Discover the top five dividend health care stocks for 2016, including two pharmaceutical giants and two newer dividend stocks ...
  66. M&A Hits a Record in 2015

    December 4, 2015
    2015 has been a record year for mergers and acquisitions as M&A activity hit record levels, fuelled by consolidation in various ...
  67. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  68. The Biggest Risks of Investing in Pfizer Stock (PFE)

    November 25, 2015
    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review ...
  69. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  70. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  71. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  72. New Treasury Rules Won't Stop Corporate Inversions (PFE, AGN)

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  73. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  74. Pfizer - Allergan: Will This Deal Happen? (PFE, AGN)

    October 30, 2015
    The question for investors is: Will this deal happen?
  75. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  76. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  77. Are Drug Price Controls Viable in the U.S.? (IPXL, ABBV)

    September 24, 2015
    Are price controls on pharmaceuticals viable in the U.S.? What effect would they have on existing drug companies and their ...
  78. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  79. Europe Regulator Approves Pfizer Buyout of Hospira (HSP, PFE)

    August 7, 2015
    Pfizer (NYSE: PFE) has gotten the green light from Europe's antitrust regulator to acquire fellow pharmaceutical Hospira ...
  80. 3 Reasons Pfizer Stock Could Rise (PFE)

    June 19, 2015
    Pfizer (NYSE: PFE) is truly facing a challenge of unprecedented magnitude at the moment. While patent issues are something ...
  81. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  82. 3 Reasons Pfizer Stock Could Fall (PFE)

    June 12, 2015
    Pharmaceutical giant Pfizer (NYSE: PFE) has been something of an anomaly over the past couple of years. Despite facing an ...
  83. Billionaire Phillip Frost Is at It Again (OPK, BRLI)

    June 8, 2015
    Over the past 40 years, Phillip Frost became one of the most respected entrepreneurs in healthcare by cobbling together ...
  84. Pfizer CEO: The Story Behind Ian Read (PFE, AZN)

    June 3, 2015
    Learn about the rise of Ian Read, the CEO of Pfizer. Pfizer is one of the most profitable and largest pharmaceutical companies ...
  85. Top 10 Pfizer Venture Investments (PFE)

    June 2, 2015
    Learn more about Pfizer Venture Investments, a private equity venture capital firm, and some of the major companies in its ...
  86. Pfizer's Ibrance Takes Another Giant Leap Forward (PFE)

    June 1, 2015
    Although its stock price may not reflect it, the past four-plus years have been perhaps the most challenging in Pfizer's ...
  87. Is Pfizer's Dividend Built to Last? (PFE)

    May 27, 2015
    Pfizer (NYSE: PFE) is the prototypical Big Pharma giant. Among megacap pharmaceutical names, Pfizer generates more revenue ...
  88. Would Pfizer Buying GlaxoSmithKline Make Sense? (GSK, PFE)

    May 22, 2015
    Over the past five years, Pfizer (NYSE: PFE) and its shareholders have witnessed its stock price ascend by approximately ...
  89. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  90. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  91. 5 Things Pfizer's Management Wants You to Know (PFE)

    May 18, 2015
    It's been just shy of three weeks since pharmaceutical juggernaut Pfizer (NYSE: PFE) reported its first-quarter earnings ...
  92. Pfizer's 3 Most Important Numbers (PFE)

    May 8, 2015
    Pfizer (NYSE: PFE) is one of the largest and most profitable pharmaceutical companies in the world. Last year alone, it ...
  93. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  94. How China Makes Money (PFE, GSK)

    April 28, 2015
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  95. How to Analyze Pharma Stock Fundamentals

    April 23, 2015
    What you need to know about analyzing the fundamentals of pharma stocks.
  96. Pfizer Earnings Preview: 5 Things You Need to Know (PFE, HSP)

    April 21, 2015
    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but ...
  97. Is This Pfizer's Next Mega-Blockbuster Drug? (PFE)

    April 16, 2015
    In February, the FDA delivered Pfizer (NYSE: PFE) some welcome news when it gave the company the go-ahead to begin marketing ...
  98. 3 Moves Pfizer Should Make for Its Shareholders (PFE, JAZZ)

    April 7, 2015
    PFE data by YCharts. Big pharmaceutical giant Pfizer (NYSE: PFE) isn't often thought of as a substantial growth driver of ...
  99. Is This Pfizer's Single Best Chance for Growth? (PFE)

    April 3, 2015
    Pfizer (NYSE: PFE) is a drug-developing Goliath, but it's struggled over the past few years to offset a drop-off in sales ...
  100. What are examples of major companies in the drugs sector?

    April 1, 2015
    Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved ...
  • Showing 1-100 of 135 items
  • 1
  • 2
  • >>
Trading Center